What is the price target for NBSE stock?
6 analysts have analysed NBSE and the average price target is 142.8 USD. This implies a price increase of 37677.78% is expected in the next year compared to the current price of 0.378.
NEUBASE THERAPEUTICS INC (NBSE) Forecast, Price Target & Analyst Ratings
NASDAQ:NBSE • US64132K2015
Current stock price
0.378 USD
-0.01 (-3.2%)
At close:
0.42 USD
+0.04 (+11.11%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NEUBASE THERAPEUTICS INC (NBSE).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
$142.80
Upside
+ 37,677.78%
From current price of $0.38 to mean target of $142.80, Based on 6 analyst forecasts
Low
$141.40
Median
$142.80
High
$147.00
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
6 Wall Street analysts provided a forecast for the next 12 months for NBSE. The average price target is 142.8 USD. This implies a price increase of 37677.78% is expected in the next year compared to the current price of 0.378.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
43.33%
NBSE was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about NBSE.
In the previous month the buy percentage consensus was at a similar level.
NBSE was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-10-21 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2022-10-18 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2022-10-17 | Chardan Capital | Downgrade | Buy -> Neutral |
| 2022-08-12 | Chardan Capital | Maintains | Buy |
| 2022-05-31 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-13 | Chardan Capital | Maintains | Buy |
| 2021-06-01 | HC Wainwright & Co. | Maintains | Buy |
| 2021-02-12 | HC Wainwright & Co. | Maintains | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Aug 12, 2024
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
Full Analyst Estimates 2024 - 2027
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | |||||||||
| EBITDA YoY % growth | -16.29M | -23.41M -43.71% | -22.61M 3.42% | -7.95M 64.84% | -25.38M -219.25% | -16.79M 33.85% | -26.17M -55.87% | -32.55M -24.38% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -17.47M | -24.59M -40.76% | -23.78M 3.29% | -9.07M 61.86% | -25.51M -181.26% | -17.07M 33.09% | -26.57M -55.65% | -33.32M -25.40% | N/A 57.12% | N/A -35.65% | N/A -31.58% | N/A 18.00% | N/A -21.95% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -10.60 | -16.80 -58.49% | N/A 30.79% | N/A | N/A | -0.89 96.58% | -0.92 -3.37% | -16.24 -1,665.22% | -7.30 55.05% | N/A -25.75% | N/A -26.67% | N/A 86.23% | N/A -17.83% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
21.21%
EPS Next 5 Year
14.88%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
NEUBASE THERAPEUTICS INC / NBSE Forecast FAQ
When does NEUBASE THERAPEUTICS INC (NBSE) report earnings?
NEUBASE THERAPEUTICS INC (NBSE) will report earnings on 2024-08-12.